Agilent Technologies (NYSE:A) Upgraded at Evercore ISI

Evercore ISI upgraded shares of Agilent Technologies (NYSE:A) from an in-line rating to an outperform rating in a report issued on Monday, Marketbeat.com reports. The brokerage currently has $160.00 target price on the medical research company’s stock, up from their previous target price of $155.00.

A number of other analysts have also recently issued reports on the company. Rothschild Redb upgraded Agilent Technologies to a “strong-buy” rating in a report on Wednesday, October 8th. Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Friday, October 3rd. JPMorgan Chase & Co. increased their price objective on shares of Agilent Technologies from $165.00 to $180.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 25th. TD Cowen raised their target price on shares of Agilent Technologies from $150.00 to $162.00 and gave the company a “buy” rating in a research note on Tuesday, October 14th. Finally, UBS Group increased their price target on Agilent Technologies from $170.00 to $180.00 and gave the company a “buy” rating in a report on Tuesday, November 25th. One analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, Agilent Technologies presently has a consensus rating of “Moderate Buy” and an average price target of $163.31.

Agilent Technologies Stock Up 0.1%

Shares of A opened at $147.81 on Monday. The firm has a market cap of $41.90 billion, a PE ratio of 32.34, a price-to-earnings-growth ratio of 4.29 and a beta of 1.29. The company’s fifty day moving average is $144.46 and its two-hundred day moving average is $132.13. Agilent Technologies has a fifty-two week low of $96.43 and a fifty-two week high of $160.27. The company has a quick ratio of 1.52, a current ratio of 1.96 and a debt-to-equity ratio of 0.45.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Monday, November 24th. The medical research company reported $1.59 EPS for the quarter, topping analysts’ consensus estimates of $1.58 by $0.01. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.The business had revenue of $1.86 billion during the quarter, compared to the consensus estimate of $1.83 billion. During the same period in the prior year, the firm posted $1.46 EPS. The business’s revenue for the quarter was up 9.4% on a year-over-year basis. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. Analysts forecast that Agilent Technologies will post 5.58 earnings per share for the current year.

Agilent Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 28th. Stockholders of record on Tuesday, January 6th will be issued a $0.255 dividend. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.25. The ex-dividend date of this dividend is Tuesday, January 6th. This represents a $1.02 annualized dividend and a dividend yield of 0.7%. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.32%.

Insider Activity

In other news, CEO Padraig Mcdonnell sold 12,490 shares of Agilent Technologies stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $150.00, for a total transaction of $1,873,500.00. Following the sale, the chief executive officer owned 33,448 shares of the company’s stock, valued at approximately $5,017,200. The trade was a 27.19% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, VP Rodney Gonsalves sold 3,000 shares of the business’s stock in a transaction dated Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total transaction of $464,970.00. Following the sale, the vice president owned 31,846 shares in the company, valued at $4,935,811.54. This trade represents a 8.61% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 16,401 shares of company stock valued at $2,468,962 in the last 90 days.

Hedge Funds Weigh In On Agilent Technologies

Institutional investors and hedge funds have recently modified their holdings of the stock. Flynn Zito Capital Management LLC lifted its holdings in Agilent Technologies by 3.2% in the 3rd quarter. Flynn Zito Capital Management LLC now owns 2,257 shares of the medical research company’s stock worth $290,000 after purchasing an additional 69 shares during the last quarter. Forum Financial Management LP raised its stake in shares of Agilent Technologies by 2.5% in the third quarter. Forum Financial Management LP now owns 2,921 shares of the medical research company’s stock worth $375,000 after acquiring an additional 70 shares during the last quarter. Gabelli Funds LLC raised its position in Agilent Technologies by 1.1% in the 3rd quarter. Gabelli Funds LLC now owns 6,620 shares of the medical research company’s stock worth $850,000 after purchasing an additional 74 shares during the last quarter. Fiduciary Trust Co lifted its position in Agilent Technologies by 1.6% during the 3rd quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock valued at $633,000 after purchasing an additional 77 shares during the period. Finally, Wedmont Private Capital lifted its stake in shares of Agilent Technologies by 2.3% in the 3rd quarter. Wedmont Private Capital now owns 3,630 shares of the medical research company’s stock valued at $503,000 after purchasing an additional 81 shares during the period.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.